Speakers:
Charlie Lockwood, MD, MHCM
Dean of the Morsani College of Medicine and Senior Vice President, University of South Florida Health, Professor, Obstetrics and Gynecology
Jodi Abbott, MD, MS
Assistant Dean of Patient Safety & Quality Improvement Education, Associate Professor Boston University School of Medicine Department of Ob/Gyn Boston Medical Center
Lisa Waddell, MD, MPH (Moderator)
Sr. Vice President Maternal Child Health & NICU, Innovation, Interim Medical Director, March of Dimes
Foundation
Preeclampsia accounts for 12% – 16% of maternal deaths in the United States, and 15% of preterm births. According to the US Preventive Services Task Force, an effective, inexpensive, and simple intervention exists to reduce rates of preeclampsia, and by many reports it appears to be underutilized. Pharmacists and providers can play a key role in reducing barriers to low-dose aspirin intake by women at risk for preeclampsia, and organizations that reach high-risk women have a key role to play in raising awareness.
This session will address the evidence and recommendations regarding low-dose aspirin to prevent preeclampsia, and describe a promising initiative intended to increase low-dose aspirin intake by lower income women and women of color. African-American women are at higher risk of entering a pregnancy with chronic hypertension and for developing preeclampsia during pregnancy.
A live webcast sponsored by:
March of Dimes and Clinical Directors Network, Inc. (CDN)
Date:
March 28, 2018 from 11:30 AM to 1:00 PM EST
Slideset –
Saving Lives: Preventing Preeclampsia With Low-Dose Aspirin (PDF)
Evaluations –
This webcast is approved for up to 1.5 Continuing Medical Education and Continuing Nursing Education credits prescribed by the American Academy of Family Physicians (AAFP). This activity has been approved for up to 1.5 continuing education credits by the Accreditation Council for Pharmacy Education. The Universal Activity Numbers assigned to this program are: 0043-9999-18-002-H01-P. Credit will be posted to CPE Monitor within six weeks.
